ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,099, issued on March 31, was assigned to Alpha Cognition Inc. (Vancouver, Canada).
"Alpha-1062 for treating traumatic brain injury" was invented by Denis G. Kay (Charlottetown, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition including a compound ALPHA-1062 or salt thereof, or a compound ALPHA-1062 or salt thereof, for use in the treatment of confirmed or suspected traumatic brain injury (TBI) in a subject. In embodiments, the composition is administered transmucosally, such as intranasally, and/or the composition is self-preserving and anti-microbial. Also disclosed is a multi-use dispenser configured for intranas...